中药降低子宫肌瘤保守术后复发率的系统评价与Meta分析
该系统评价纳入16项随机对照试验,评估中药预防子宫肌瘤术后复发的疗效与安全性。Meta分析显示,与空白对照、常规西药及中药联合西药相比,中药均显著降低术后复发率,并改善临床有效率、血清性激素水平、血浆黏度和子宫体积,安全性较好。
要点
- 中药可显著降低子宫肌瘤术后复发率,与空白对照、西药及联合治疗相比均有效。
- 中药还能改善临床有效率、恢复血清性激素水平、降低血浆黏度、促进子宫体积恢复。
- 中药总体安全性较好,不良反应发生率低,但证据质量有限需更高质量研究验证。
核心结论
- 中药可有效预防子宫肌瘤术后复发,在总体疗效、恢复性激素水平、改善血液流变学指标及促进子宫恢复方面表现良好且安全。
- 上述发现为初步结论,仍需更高质量研究验证。
研究设计与样本
- 系统评价与Meta分析,检索PubMed、Cochrane、Embase、Web of Science、CNKI、VIP、万方、CBM至2025年3月,纳入16项随机对照试验。
- 采用Cochrane Risk of Bias 2.0工具评估质量,Review Manager 5.4进行Meta分析,GRADEpro 3.2.2评估证据质量,PROSPERO注册号CRD420251000288。
主要发现
- 与空白对照相比,中药降低术后复发率(6项试验,n=588;OR=0.22;95%CI=0.14-0.34;I2=0%;p<0.00001)。
- 与常规西药相比,中药降低术后复发率(1项试验,n=80;OR=0.30;95%CI=0.09-0.93;p=0.04)。
- 中药联合西药相比,降低术后复发率(9项试验,n=959;OR=0.29;95%CI=0.19-0.46;I2=0%;p<0.00001)。
- 中药在提高临床有效率、恢复血清性激素水平、降低血浆黏度、缩小子宫体积方面也有效。
- 中药总体被认为安全,不良反应发生率低。
关键数值与推荐
- 复发率:空白对照OR=0.22(95%CI 0.14-0.34,p<0.00001);常规西药OR=0.30(95%CI 0.09-0.93,p=0.04);中药联合西药OR=0.29(95%CI 0.19-0.46,p<0.00001)。
临床怎么用
- 对于有子宫肌瘤保守手术史的患者,可考虑在术后配合中药治疗以降低复发风险。
- 中药可作为术后辅助治疗,与常规西药联用可能进一步降低复发率。
- 使用中药时需关注其对性激素水平和血液流变学的改善作用,并监测安全性。
局限性
- 纳入研究数量有限,部分比较仅基于少量试验。
- 证据质量需通过GRADE评估,结论为初步性,需更高质量研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Since surgery can only remove lesions of a larger size visible to the naked eye, the recurrence rate of uterine fibroids after surgery is high. In recent years, numerous scholars have found that traditional Chinese medicine (TCM) treatment is effective in reducing the recurrence rate of postoperative fibroids, as well as improving the clinical treatment rate, regulating serum hormone levels, reducing plasma viscosity, and promoting the restoration of uterine volume following surgery. Several randomized controlled trials have been undertaken on the prevention and treatment of postoperative recurrence of uterine fibroids using patented Chinese medicines and self-proposed formulations, such as Guizhi Fuling Pill, Xiaozheng decoction, Xiangleng pill, Zhengjia decoction, Xiaoliu decoction, Guizhi Jiliu pill, Huoxue Huayu formula, Huoxue Xiaozheng decoction, Shugan Sanjie decoction, Gongliuxiao capsule, Hongjin Xiaojie concentrated pill, and Jiawei Guizhi Fuling decoction. However, no study has systematically evaluated Chinese herbal medicine (CHM) in reducing the recurrence rate of uterine fibroids after surgery. AIM OF THE STUDY: This study aimed to conduct a meta-analysis of randomized controlled trials of CHM for the prevention of postoperative recurrence of uterine fibroids, evaluating its efficacy and safety. MATERIALS AND METHODS: A comprehensive search was conducted on PubMed, Cochrane, Embase, Web of Science, China National Knowledge Infrastructure (CNKI), VIP Information Database (VIP), WanFang Database, and China Biomedical Database (CBM) to identify randomized controlled clinical studies conducted up to March 2025 that examined the efficacy of CHM in treating patients with postoperative uterine fibroids. Two institutes were independently under-selected, and data were extracted and quality assessed using the Cochrane Risk of Bias 2.0 tool. Meta-analyses were performed using Review Manager software 5.4, and forest plots were generated. The quality of evidence was assessed using GRADEpro 3.2.2. This study was registered in PROSPERO (CRD420251000288). RESULTS: 16 trials were included in this study, and the postoperative recurrence rate after treatment was mainly analyzed. CHM treatment reduces postoperative recurrence rates in patients with uterine fibroids compared to the blank (6 trials, n = 588; OR (odds ratio) = 0.22; 95% CI (95% confidence intervals) = 0.14-0.34; I2 = 0%, p < 0.00001), conventional western medicine (CWM) (1 trial, n = 80; OR = 0.30; 95% CI = 0.09-0.93, p = 0.04), and combined CHM with CWM (9 trials, n = 959; OR = 0.29; 95% CI = 0.19-0.46; I2 = 0%, p < 0.00001). In addition, CHM is also effective in improving clinical efficiency, restoring serum sex hormone levels, lowering plasma viscosity, and reducing uterine volume. CHM is generally considered safe, with a low incidence of adverse reactions. CONCLUSION: CHM is effective in avoiding recurrence of uterine fibroids after surgery, excelling in terms of overall effectiveness, restoring female hormone levels, improving hemorheological indices, and promoting uterine recovery and safety. However, these findings are preliminary and still need to be validated by higher-quality studies.
引用
- Liu Z, Liu Y, Li S, et al. Exploring the therapeutic role of Chinses herbal medicine in the recurrence rate of uterine fibroids after conservative surgery: a systematic review and meta-analysis. J Ethnopharmacol. 2026. PMID: 42962945. doi:10.1016/j.jep.2026.121203
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。